BioMarin Pharmaceuticals Inc BMRN
$68.53
-2.43%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (14 Buy · 5 Hold · 0 Sell)
- Average Price Target
- $88.37
- Implied Upside
- +28.9%
- Price Target Range
- $60.00 – $124.00
- Analysts (12 mo)
- 19
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-10 | Canaccord GenuityWhitney Ijem |
Maintains | Buy | $111 → $114 |
| 2026-08-07 | Morgan StanleyMatthew Harrison |
Maintains | Overweight | $119 → $124 |
| 2026-08-07 | OppenheimerLeland Gershell |
Maintains | Outperform | $95 → $97 |
| 2026-08-07 | HC Wainwright & Co.Mitchell S. Kapoor |
Maintains | Neutral | $50 → $60 |
| 2026-07-16 | CitigroupEric Joseph |
Maintains | Buy | $75 → $76 |
| 2026-07-07 | RBC CapitalLuca Issi |
Maintains | Sector perform | $66 → $62 |
| 2026-05-22 | Canaccord GenuityWhitney Ijem |
Maintains | Buy | $116 → $111 |
| 2026-05-19 | B of A SecuritiesJason Zemansky |
Maintains | Buy | $85 → $80 |
| 2026-05-19 | CitigroupEric Joseph |
Initiates coverage on | Buy | $75 |
| 2026-05-18 | HC Wainwright & Co.Mitchell S. Kapoor |
Maintains | Neutral | $55 → $50 |
| 2026-05-11 | Goldman SachsSalveen Richter |
Reinstates | Buy → Neutral | $69 |
| 2026-05-07 | Canaccord GenuityWhitney Ijem |
Maintains | Buy | $104 → $116 |
| 2026-05-05 | BernsteinWilliam Pickering |
Maintains | Outperform | $94 → $82 |
| 2026-05-05 | Morgan StanleyMatthew Harrison |
Maintains | Overweight | $120 → $119 |
| 2026-05-05 | RBC CapitalLuca Issi |
Reiterates | Sector perform | $66 |
| 2026-05-05 | Evercore ISI GroupCory Kasimov |
Maintains | Outperform | $110 → $120 |
| 2026-05-05 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Neutral | $55 |
| 2026-03-11 | B of A SecuritiesGeoff Meacham |
Maintains | Buy | $97 → $85 |
| 2026-03-04 | BarclaysEliana Merle |
Maintains | Overweight | $80 → $105 |
| 2026-03-02 | Freedom BrokerIlya Zubkov |
Maintains | Buy | $100 → $105 |
| 2026-03-02 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Neutral | $55 |
| 2026-02-26 | Canaccord GenuityWhitney Ijem |
Maintains | Buy | $98 → $104 |
| 2026-02-25 | BernsteinWilliam Pickering |
Maintains | Outperform | $90 → $94 |
| 2026-02-25 | GuggenheimDebjit Chattopadhyay |
Maintains | Buy | $106 → $86 |
| 2026-02-25 | HC Wainwright & Co.Mitchell S. Kapoor |
Maintains | Neutral | $60 → $55 |
| 2026-02-24 | OppenheimerLeland Gershell |
Maintains | Outperform | $98 → $95 |
| 2026-02-18 | Wells FargoMohit Bansal |
Maintains | Overweight | $70 → $75 |
| 2026-02-06 | Piper SandlerAllison Bratzel |
Maintains | Overweight | $122 → $84 |
| 2026-01-20 | Canaccord GenuityWhitney Ijem |
Upgrades | Hold → Buy | $84 → $98 |
| 2025-12-23 | Truist SecuritiesJoon Lee |
Maintains | Buy | $80 → $100 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $68.53
- Market Cap
- $13.60 billion
- 52-Week Range
- $49.26 – $70.98
- Average Volume
- 2.00 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.